Trial Outcomes & Findings for FluSAFE: Flu SMS Alerts to Freeze Exposure (NCT NCT03274310)

NCT ID: NCT03274310

Last Updated: 2025-01-16

Results Overview

One self-swab of the index case and self-swabs of other household members will be analyzed using reverse transcription polymerase chain reaction (RT-PCR) to identify household transmission of laboratory-confirmed influenza.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1918 participants

Primary outcome timeframe

Up to 5 days

Results posted on

2025-01-16

Participant Flow

Unit of analysis: households

Participant milestones

Participant milestones
Measure
Surveillance + Education Arm
Receipt of educational text message about ways to decrease household transmission of influenza and other respiratory infections in addition to surveillance messages Educational text messages: Educational text message about ways to decrease household transmission of influenza and other respiratory infections
Surveillance-only Arm
No intervention solely surveillance messages
Overall Study
STARTED
959 203
959 208
Overall Study
COMPLETED
959 203
959 208
Overall Study
NOT COMPLETED
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

FluSAFE: Flu SMS Alerts to Freeze Exposure

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Surveillance + Education Arm
n=959 Participants
Receipt of educational text message about ways to decrease household transmission of influenza and other respiratory infections in addition to surveillance messages Educational text messages: Educational text message about ways to decrease household transmission of influenza and other respiratory infections
Surveillance-only Arm
n=959 Participants
No intervention solely surveillance messages
Total
n=1918 Participants
Total of all reporting groups
Age, Customized
Age · <18 years
468 Participants
n=5 Participants
448 Participants
n=7 Participants
916 Participants
n=5 Participants
Age, Customized
Age · 18 years and over
491 Participants
n=5 Participants
511 Participants
n=7 Participants
1002 Participants
n=5 Participants
Sex: Female, Male
Female
546 Participants
n=5 Participants
518 Participants
n=7 Participants
1064 Participants
n=5 Participants
Sex: Female, Male
Male
413 Participants
n=5 Participants
441 Participants
n=7 Participants
854 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
133 Participants
n=5 Participants
132 Participants
n=7 Participants
265 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
824 Participants
n=5 Participants
827 Participants
n=7 Participants
1651 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Up to 5 days

One self-swab of the index case and self-swabs of other household members will be analyzed using reverse transcription polymerase chain reaction (RT-PCR) to identify household transmission of laboratory-confirmed influenza.

Outcome measures

Outcome measures
Measure
Surveillance + Education Arm
n=959 Participants
Receipt of educational text message about ways to decrease household transmission of influenza and other respiratory infections in addition to surveillance messages Educational text messages: Educational text message about ways to decrease household transmission of influenza and other respiratory infections
Surveillance-only Arm
n=959 Participants
No intervention solely surveillance messages
Number of Laboratory-confirmed Influenza Infections
.22 infections
Standard Error 0.04
.14 infections
Standard Error 0.05

SECONDARY outcome

Timeframe: Up to 5 days

The CDC-provided case definition for ARI is presence of at least two of the following: 1) rhinorrhea/nasal congestion; 2) sore throat; 3) cough; 4) fever/feverishness; 5) myalgia. The ILI definition is at least two of the following signs and symptoms: fever, cough, headache, sore throat, or myalgia.

Outcome measures

Outcome measures
Measure
Surveillance + Education Arm
n=959 Participants
Receipt of educational text message about ways to decrease household transmission of influenza and other respiratory infections in addition to surveillance messages Educational text messages: Educational text message about ways to decrease household transmission of influenza and other respiratory infections
Surveillance-only Arm
n=959 Participants
No intervention solely surveillance messages
Number of Cases of Household Members Meeting Symptomatic Criteria for ILI/ARI
.20 infections
Standard Error .01
.19 infections
Standard Error .01

SECONDARY outcome

Timeframe: Up to 5 days

This outcome will measure household transmission of non-influenza respiratory viruses. One self-swab of the index case and self-swabs of other household members will be analyzed using RT-PCR to identify household transmission of non-influenza respiratory viruses

Outcome measures

Outcome measures
Measure
Surveillance + Education Arm
n=959 Participants
Receipt of educational text message about ways to decrease household transmission of influenza and other respiratory infections in addition to surveillance messages Educational text messages: Educational text message about ways to decrease household transmission of influenza and other respiratory infections
Surveillance-only Arm
n=959 Participants
No intervention solely surveillance messages
Number of Infections of Non-influenza Respiratory Viruses
.27 infections
Standard Error .02
.23 infections
Standard Error .02

Adverse Events

Surveillance + Education Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Surveillance-only Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Melissa Stockwell

Columbia University Vagelos College of Physicians and Surgeons

Phone: 2123425732

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place